Home page     Newsletter    Feedback   Weblinks Vietnamese 
Friday, December 27, 2024 Search
 Advanced Search
  Home » News » News »  

Viet Nam to produce Tamiflu

(VNA) - Three pharmaceutical companies of Viet Nam will begin producing Tamiflu, the drug used for treating bird flu in humans caused by the lethal H5N1 virus, between now and December.

Cao Minh Quang, director of the Viet Nam Pharmaceuticals Administration Department, further said that the decision was made following his negotiations with Roche Pharmaceuticals.

Quang told a meeting of the steering committee for preventing and controlling SARS and other dangerous epidemics in Ha Noi on Oct. 26 that the nation should stockpile 25 million doses of Tamiflu to ensure sufficient drugs to treat a quarter of the patients who would contract the H5N1 strain, during a pandemic.

Director of the Treatment Department Ly Ngoc Kinh said he estimated about one-tenth of the population might be infected by the flu if a pandemic ocurred.

Prof. Tran Quy, Director of Bach Mai Hospital, and a number of medical experts were of the same view that detected avian flu victims should be treated at the disease pandemic-stricken area, and that an all-out effort should be made to promptly contain it.

They also recommended the Health Ministry work out measures to protect medical workers involved in controlling and preventing a pendemic. Those medical workers, they said, should be vaccinated against the flu as well as provided with protected equipment.

Local health experts pointed to the need to update Viet Nam's current roadmap for treating flu patients infected with H5N1 virus, based on the regional's and world's experiences in treating bird flu./.

 
Back Top page Print Email

Bản quyền của Vụ Thông Tin Báo Chí - Bộ Ngoại Giao
© Copyright by Press and Information Department - Vietnam Ministry of Foreign Affairs
Email: Banbientap@mofa.gov.vn 
Hiển thị tốt nhất với Internet Explorer. Best viewed with Internet Explorer